Logos-Global-Management-Lp

AI_NATIVE detailed information: This accession holds the following tickers:[
  "OCUL",
  "AKRO",
  "NUVL",
  "TRVI",
  "RVMD",
  "ANNX",
  "ATXS",
  "OLMA",
  "GPCR",
  "RAPP",
  "KROS",
  "ALLK",
  "JANX",
  "ARTV",
  "GERN",
  null,
  "SEPN",
  "UNCY",
  null,
  "ACRS",
  "IDYA",
  "TEVA",
  "RNA",
  null,
  "SLDB",
  "MLTX",
  "SLNO",
  "ETNB",
  "DYN",
  "GLYC",
  "CMPS",
  "ERAS",
  "ELVN",
  "DSGN",
  "XENE",
  "IMVT",
  "BNTX",
  "CRNX",
  "IRON"
]

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 39
Total Value: 562541126
Accession Number: 0001172661-25-002012
Form Type: 13F-HR
CIK: logos-global-management-lp
Manager Name: Logos-Global-Management-Lp

Data Enrichment

92% identified

36 identified3 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

39 positions • $562.5M total value

SEC FilingSEC DataHachi Filing

Manager:

Search and click to pin securities to the top

Page 2 of 2

Sort by:

578784100

Shares:936.9K

Value:$10.3M

% of Portfolio:1.8% ($10.3M/$562.5M)

Annexon, Inc.

ANNX|03589W102

Shares:4.0M

Value:$7.7M

% of Portfolio:1.4% ($7.7M/$562.5M)

Structure Therapeutics Inc.

GPCR|86366E106

Shares:425.0K

Value:$7.4M

% of Portfolio:1.3% ($7.4M/$562.5M)

COMPASS Pathways plc

CMPS|20451W101

Shares:2.0M

Value:$5.7M

% of Portfolio:1.0% ($5.7M/$562.5M)

Dyne Therapeutics, Inc.

DYN|26818M108

Shares:500.0K

Value:$5.2M

% of Portfolio:0.9% ($5.2M/$562.5M)

Enliven Therapeutics, Inc.

ELVN|29337E102

Shares:240.0K

Value:$4.7M

% of Portfolio:0.8% ($4.7M/$562.5M)

Immunovant, Inc.

IMVT|45258J102

Shares:275.0K

Value:$4.7M

% of Portfolio:0.8% ($4.7M/$562.5M)

008064107

Shares:1.4M

Value:$3.5M

% of Portfolio:0.6% ($3.5M/$562.5M)

Aclaris Therapeutics, Inc.

ACRS|00461U105

Shares:2.2M

Value:$3.4M

% of Portfolio:0.6% ($3.4M/$562.5M)

Unicycive Therapeutics, Inc.

UNCY|90466Y103

Shares:5.1M

Value:$2.9M

% of Portfolio:0.5% ($2.9M/$562.5M)

Trevi Therapeutics, Inc.

TRVI|89532M101

Shares:424.7K

Value:$2.7M

% of Portfolio:0.5% ($2.7M/$562.5M)

Astria Therapeutics, Inc.

ATXS|04635X102

Shares:500.0K

Value:$2.7M

% of Portfolio:0.5% ($2.7M/$562.5M)

Rapport Therapeutics, Inc.

RAPP|75383L102

Shares:208.9K

Value:$2.1M

% of Portfolio:0.4% ($2.1M/$562.5M)

GLYCOMIMETICS INC

GLYC|38000Q102

Shares:5.4M

Value:$1.1M

% of Portfolio:0.2% ($1.1M/$562.5M)

Septerna, Inc.

SEPN|81734D104

Shares:134.2K

Value:$777.0K

% of Portfolio:0.1% ($777.0K/$562.5M)

Allakos Inc.

ALLK|01671P100

Shares:2.9M

Value:$660.0K

% of Portfolio:0.1% ($660.0K/$562.5M)

Artiva Biotherapeutics, Inc.

ARTV|04317A107

Shares:145.1K

Value:$435.3K

% of Portfolio:0.1% ($435.3K/$562.5M)

Solid Biosciences Inc.

SLDB|83422E204

Shares:100.0K

Value:$370.0K

% of Portfolio:0.1% ($370.0K/$562.5M)

67080N119

Shares:66.7K

Value:$15.9K

% of Portfolio:0.0% ($15.9K/$562.5M)

Instrument	Shares		Other Manager	Value	% of Portfolio
(cusip578784100)✕	936.9K	QoQ NEW(+936.9K) YoY NEW(+936.9K)	All Managers (Combined)	$10.3M	1.8% ($10.3M/$562.5M)	QoQ NEW(+$10.3M) YoY NEW(+$10.3M)
Annexon, Inc.(ANNXcusip03589W102)	4.0M	QoQ +56.86% (-1.4M) YoY +300.00% (+3.0M)	All Managers (Combined)	$7.7M	1.4% ($7.7M/$562.5M)	QoQ -40.98% (-$5.4M) YoY +7.67% (+$550.0K)
Structure Therapeutics Inc.(GPCRcusip86366E106)	425.0K	QoQ -39.28% (-275.0K) YoY -5.55% (-25.0K)	All Managers (Combined)	$7.4M	1.3% ($7.4M/$562.5M)	QoQ -61.24% (-$11.6M) YoY -61.85% (-$11.9M)
COMPASS Pathways plc(CMPScusip20451W101)	2.0M	QoQ NEW(+2.0M) YoY +675.25% (+1.7M)	All Managers (Combined)	$5.7M	1.0% ($5.7M/$562.5M)	QoQ NEW(+$5.7M) YoY +215.39% (+$3.9M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	500.0K	QoQ +11.11% (-50.0K) YoY -71.09% (-1.2M)	All Managers (Combined)	$5.2M	0.9% ($5.2M/$562.5M)	QoQ -50.66% (-$5.4M) YoY -89.35% (-$43.9M)
Enliven Therapeutics, Inc.(ELVNcusip29337E102)	240.0K	QoQ +71.42% (+100.0K) YoY -84.75% (-1.3M)	All Managers (Combined)	$4.7M	0.8% ($4.7M/$562.5M)	QoQ +49.94% (+$1.6M) YoY -82.11% (-$21.7M)
Immunovant, Inc.(IMVTcusip45258J102)	275.0K	QoQ -8.33% (-25.0K) YoY -84.50% (-1.5M)	All Managers (Combined)	$4.7M	0.8% ($4.7M/$562.5M)	QoQ -36.75% (-$2.7M) YoY -91.80% (-$52.7M)
(cusip008064107)✕	1.4M	QoQ 0.00% (-0) YoY NEW(+1.4M)	All Managers (Combined)	$3.5M	0.6% ($3.5M/$562.5M)	QoQ -5.28% (-$196.0K) YoY NEW(+$3.5M)
Aclaris Therapeutics, Inc.(ACRScusip00461U105)	2.2M	QoQ 0.00% (-0) YoY NEW(+2.2M)	All Managers (Combined)	$3.4M	0.6% ($3.4M/$562.5M)	QoQ -38.30% (-$2.1M) YoY NEW(+$3.4M)
Unicycive Therapeutics, Inc.(UNCYcusip90466Y103)	5.1M	QoQ 0.00% (-0) YoY +46.36% (-1.6M)	All Managers (Combined)	$2.9M	0.5% ($2.9M/$562.5M)	QoQ -27.61% (-$1.1M) YoY -3.02% (-$91.0K)
Trevi Therapeutics, Inc.(TRVIcusip89532M101)	424.7K	QoQ -66.02% (-825.3K) YoY -80.69% (-1.8M)	All Managers (Combined)	$2.7M	0.5% ($2.7M/$562.5M)	QoQ -48.12% (-$2.5M) YoY -64.80% (-$4.9M)
Astria Therapeutics, Inc.(ATXScusip04635X102)	500.0K	QoQ 0.00% (-0) YoY -59.83% (-745.0K)	All Managers (Combined)	$2.7M	0.5% ($2.7M/$562.5M)	QoQ -40.26% (-$1.8M) YoY -84.76% (-$14.9M)
Rapport Therapeutics, Inc.(RAPPcusip75383L102)	208.9K	QoQ 0.00% (-0) YoY NEW(+208.9K)	All Managers (Combined)	$2.1M	0.4% ($2.1M/$562.5M)	QoQ -43.46% (-$1.6M) YoY NEW(+$2.1M)
GLYCOMIMETICS INC(GLYCcusip38000Q102)	5.4M	QoQ 0.00% (-0) YoY NEW(+5.4M)	All Managers (Combined)	$1.1M	0.2% ($1.1M/$562.5M)	QoQ -15.66% (-$210.6K) YoY NEW(+$1.1M)
Septerna, Inc.(SEPNcusip81734D104)	134.2K	QoQ 0.00% (-0) YoY NEW(+134.2K)	All Managers (Combined)	$777.0K	0.1% ($777.0K/$562.5M)	QoQ -74.71% (-$2.3M) YoY NEW(+$777.0K)
Allakos Inc.(ALLKcusip01671P100)	2.9M	QoQ 0.00% (-0) YoY 0.00% (-0)	All Managers (Combined)	$660.0K	0.1% ($660.0K/$562.5M)	QoQ -81.19% (-$2.8M) YoY -81.93% (-$3.0M)
Artiva Biotherapeutics, Inc.(ARTVcusip04317A107)	145.1K	QoQ 0.00% (-0) YoY NEW(+145.1K)	All Managers (Combined)	$435.3K	0.1% ($435.3K/$562.5M)	QoQ -70.23% (-$1.0M) YoY NEW(+$435.3K)
Solid Biosciences Inc.(SLDBcusip83422E204)	100.0K	QoQ NEW(+100.0K) YoY NEW(+100.0K)	All Managers (Combined)	$370.0K	0.1% ($370.0K/$562.5M)	QoQ NEW(+$370.0K) YoY NEW(+$370.0K)
(cusip67080N119)✕	66.7K	QoQ 0.00% (+0) YoY 0.00% (-0)	All Managers (Combined)	$15.9K	0.0% ($15.9K/$562.5M)	QoQ +3.82% (+$587) YoY -30.00% (-$6.8K)